ExThera Medical Corporation, based in Martinez, CA, is a pioneering medical device company that specializes in developing innovative therapies for critical care patients. Their flagship product, the Seraph 100 Microbind Affinity Blood Filter, is a groundbreaking hemoperfusion technology designed to address unmet clinical needs in the treatment of severe COVID-19 and bloodstream infections. With a focus on pathogen absorption and blood purification, ExThera Medical is at the forefront of providing advanced solutions for patients in critical conditions.
Additionally, ExThera Medical has launched the OncoBind Extracorporeal Procedure Program, an investigational device exemption (IDE) study aimed at treating metastatic cancer patients. This program showcases their commitment to developing cutting-edge therapies that have the potential to revolutionize cancer treatment. Through their dedication to innovation and patient care, ExThera Medical is making significant strides in improving outcomes for critically ill individuals.
Generated from the website